ArticleAnnals of the Child Neurology Society2023
Impact of infections on the incidence of acute inflammatory demyelinating polyneuropathy in children.
Article in Annals of the Child Neurology Society, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Acute inflammatory demyelinating polyneuropathy (AIDP) is the leading cause of acute flaccid paralysis in children and hypothesized to be triggered by antecedent infection. We sought to determine the association between AIDP and commonly acquired community infections in children. We utilized the reduction in these infections due to measures during coronavirus disease 2019 (COVID-19) to serve as a natural experiment and determine their contribution to AIDP. Methods: This cross-sectional study used administrative and billing data from children's hospitals contributing to the Pediatric Health Information System. We included hospitalizations of children with a diagnosis of AIDP from (January 2017 through February 2021). Encounters for infection- (including respiratory, gastrointestinal, and COVID-19) related diagnoses were measured as a marker of community incidence. Results: A total of 1111 index encounters for AIDP were included. Pre-COVID-19, AIDP was not associated with respiratory or gastrointestinal infections, specifically, influenza or campylobacter. During the COVID-19 period from March 2020 to February 2021, respiratory, gastrointestinal, and influenza infections decreased compared to expected (for the same time of year pre-COVID-19) by 59.6%-90.1%, 51.5%-68.9%, and 54.5%-97.9%, respectively. In contrast, AIDP hospitalizations and all hospitalizations only decreased by 11.5%-39.3% and 14.2%-25%, respectively. COVID-19 was not positively associated with AIDP overall or at individual hospitals. Interpretation: Common community-acquired infections including COVID-19 were not strongly associated with hospitalizations for AIDP in children. AIDP persisted despite the dramatic reduction in infection-related encounters during the pandemic. These results suggest that recent antecedent community-acquired infections were not the primary driver of AIDP and that alternative triggers should be explored.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.